OptimizeRx to Present at 8th Annual LD Micro Invitational Conference on June 5, 2018
ROCHESTER, MI / ACCESSWIRE / May 21, 2018 / OptimizeRx Corp. (OTCQB: OPRX), the nation's leading provider of digital health messaging for the pharmaceutical industry, has been invited to present at 8th Annual LD Micro Invitational Conference being held on June 4-6, 2018 at the Luxe Sunset Bel Air Hotel in Bel Air, California.
OptimizeRx CEO William Febbo is scheduled to present on Tuesday, June 5, at 8:30 a.m. Pacific time, with one-on-one meetings held throughout the day. He will discuss OptimizeRx's record Q1 results, expanded exclusive partnership, and its growing network that reaches more than half of the ambulatory patient market in the U.S.
The LD Micro Invitational Conference is one of the nation's largest independent conferences for small/micro-cap companies, with more than 230 names presenting to 1,000+ attendees. The conference will also feature a variety of speakers and panelists discussing topics of interest to investors and issuers, as well as evening social events.
To schedule a one-on-one meeting with OptimizeRx, you may submit your request online via the link provided upon registration. To register for the conference, contact David Scher at firstname.lastname@example.org or visit www.ldmicro.com/events. For any questions about the company, contact Ron Both of CMA at (949) 432-7557 or submit your request here.
View OptimizeRx's LD Micro profile here: https://www.ldmicro.com/profile/OPRX.
About LD Micro
LD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space. What started out as a newsletter highlighting unique companies has transformed into several influential conferences annually. In 2015, LDM launched the first pure microcap index (the LDMi) to exclusively provide intraday information on the entire sector. For more information about LD Micro, go to www.ldmicro.com/events.
OptimizeRx® (OTCQB: OPRX) is the nation's leading provider of digital health messaging via electronic health records (EHRs), providing a direct channel for pharma companies to communicate with healthcare providers. The company's cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, education, and critical clinical information. The company's network is comprised of leading EHR platforms like Allscripts, Amazing Charts and Quest, and provides more than half of the ambulatory patient market access to these benefits within their workflow at the point of care. For more information, follow the company on Twitter, LinkedIn or visit www.optimizerx.com.
Important Cautions Regarding Forward Looking Statements
This press release contains forward-looking statements within the definition of Section 27A of the Securities Act of 1933, as amended and such section 21E of the Securities Act of 1934, amended. These forward-looking statements should not be used to make an investment decision. The words 'estimate,' 'possible' and 'seeking' and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.
Doug Baker, CFO
Tel (248) 651-6568 x807
Investor Relations Contact:
Ron Both, CMA
Tel (949) 432-7557
SOURCE: OptimizeRx Corp.